Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
71.50
+2.04 (2.94%)
At close: May 30, 2025, 4:00 PM
71.20
-0.30 (-0.42%)
After-hours: May 30, 2025, 7:59 PM EDT

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of $305.07 billion. The enterprise value is $316.76 billion.

Market Cap 305.07B
Enterprise Value 316.76B

Important Dates

The last earnings date was Wednesday, May 7, 2025, before market open.

Earnings Date May 7, 2025
Ex-Dividend Date Mar 31, 2025

Share Statistics

Novo Nordisk has 4.44 billion shares outstanding. The number of shares has decreased by -0.61% in one year.

Current Share Class n/a
Shares Outstanding 4.44B
Shares Change (YoY) -0.61%
Shares Change (QoQ) -0.20%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 3.18B

Valuation Ratios

The trailing PE ratio is 21.02 and the forward PE ratio is 17.08.

PE Ratio 21.02
Forward PE 17.08
PS Ratio 6.95
Forward PS 1.18
PB Ratio 15.20
P/TBV Ratio 72.20
P/FCF Ratio 25.34
P/OCF Ratio 16.04
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.08, with an EV/FCF ratio of 26.31.

EV / Earnings 20.90
EV / Sales 7.21
EV / EBITDA 14.08
EV / EBIT 14.89
EV / FCF 26.31

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.86.

Current Ratio 0.74
Quick Ratio 0.54
Debt / Equity 0.86
Debt / EBITDA 0.76
Debt / FCF 1.43
Interest Coverage 41.95

Financial Efficiency

Return on equity (ROE) is 88.12% and return on invested capital (ROIC) is 47.91%.

Return on Equity (ROE) 88.12%
Return on Assets (ROA) 23.29%
Return on Invested Capital (ROIC) 47.91%
Return on Capital Employed (ROCE) 58.02%
Revenue Per Employee $567,845
Profits Per Employee $195,965
Employee Count 77,349
Asset Turnover 0.77
Inventory Turnover 1.22

Taxes

In the past 12 months, Novo Nordisk has paid $4.01 billion in taxes.

Income Tax 4.01B
Effective Tax Rate 20.93%

Stock Price Statistics

The stock price has decreased by -46.11% in the last 52 weeks. The beta is 0.21, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y) 0.21
52-Week Price Change -46.11%
50-Day Moving Average 66.66
200-Day Moving Average 95.67
Relative Strength Index (RSI) 59.51
Average Volume (20 Days) 11,135,672

Short Selling Information

The latest short interest is 27.58 million, so 0.82% of the outstanding shares have been sold short.

Short Interest 27.58M
Short Previous Month 19.07M
Short % of Shares Out 0.82%
Short % of Float n/a
Short Ratio (days to cover) 2.36

Income Statement

In the last 12 months, Novo Nordisk had revenue of $43.92 billion and earned $15.16 billion in profits. Earnings per share was $3.40.

Revenue 43.92B
Gross Profit 37.18B
Operating Income 21.27B
Pretax Income n/a
Net Income 15.16B
EBITDA 22.50B
EBIT 21.27B
Earnings Per Share (EPS) $3.40
Full Income Statement

Balance Sheet

The company has $6.02 billion in cash and $17.20 billion in debt, giving a net cash position of -$11.18 billion or -$2.52 per share.

Cash & Cash Equivalents 6.02B
Total Debt 17.20B
Net Cash -11.18B
Net Cash Per Share -$2.52
Equity (Book Value) 20.07B
Book Value Per Share 4.52
Working Capital -8.94B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $19.02 billion and capital expenditures -$7.55 billion, giving a free cash flow of $12.04 billion.

Operating Cash Flow 19.02B
Capital Expenditures -7.55B
Free Cash Flow 12.04B
FCF Per Share $2.71
Full Cash Flow Statement

Margins

Gross margin is 84.65%, with operating and profit margins of 48.43% and 34.51%.

Gross Margin 84.65%
Operating Margin 48.43%
Pretax Margin 43.65%
Profit Margin 34.51%
EBITDA Margin 51.23%
EBIT Margin 48.43%
FCF Margin 27.41%

Dividends & Yields

This stock pays an annual dividend of $1.61, which amounts to a dividend yield of 2.25%.

Dividend Per Share $1.61
Dividend Yield 2.25%
Dividend Growth (YoY) 17.49%
Years of Dividend Growth 3
Payout Ratio 47.38%
Buyback Yield 0.61%
Shareholder Yield 2.86%
Earnings Yield 4.97%
FCF Yield 3.95%
Dividend Details

Analyst Forecast

The average price target for Novo Nordisk is $128.00, which is 79.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target $128.00
Price Target Difference 79.02%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 12.53%
EPS Growth Forecast (5Y) 13.97%
Stock Forecasts

Stock Splits

The last stock split was on September 20, 2023. It was a forward split with a ratio of 2:1.

Last Split Date Sep 20, 2023
Split Type Forward
Split Ratio 2:1

Scores

Novo Nordisk has an Altman Z-Score of 7.88 and a Piotroski F-Score of 5.

Altman Z-Score 7.88
Piotroski F-Score 5